CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
CareDx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$67.08+3.08 (+4.81%)
Close on Oct 19, 2026
- Market cap
- $3.58B
- P/E (TTM)
- 32.4
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
53M of 52M shares
Institutional holders
227
54 new, 13 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 26 sales
Net sold $13.31M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,664,092 | 9.00% | 13G (passive) amendment | Jun 30, 2026 |
| Bellevue Group AG | 3,145,546 | 5.90% | 13G (passive) amendment | Nov 14, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CDNA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,814,709 | 9.31% | $137.22M | +292,613 | 0.00% |
| State Street Corp | 2,468,858 | 4.77% | $70.36M | −291,527 | 0.00% |
| Vanguard Capital Management LLC | 2,197,475 | 4.25% | $62.63M | +37,018 | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 1,997,618 | 3.86% | $56.93M | −193,382 | 0.59% |
| ARK Investment Management LLC | 1,953,531 | 3.78% | $55.68M | −274,025 | 0.36% |
| Boston Partners | 1,937,601 | 3.75% | $55.22M | +54,067 | 0.05% |
| Bamco Inc /Ny/ | 1,937,326 | 3.74% | $55.21M | −1,399,083 | 0.08% |
| Gagnon Securities LLC | 1,770,735 | 3.42% | $50.47M | +8,861 | 9.73% |
| Chevy Chase Trust Holdings, LLC | 1,437,416 | 2.78% | $40.97M | −66,659 | 0.11% |
| Geode Capital Management, LLC | 1,328,037 | 2.57% | $37.86M | +73,923 | 0.00% |
| Ophir Asset Management Pty Ltd | 1,264,809 | 2.44% | $36.05M | +276,758 | 2.96% |
| Renaissance Technologies LLC | 1,242,959 | 2.40% | $35.42M | +58,561 | 0.05% |
| Braidwell LP | 1,220,602 | 2.36% | $34.79M | −952,544 | 1.29% |
| First Eagle Investment Management, LLC | 1,196,994 | 2.31% | $34.11M | +621,629 | 0.03% |
| Sumitomo Mitsui Trust Holdings, Inc. | 1,191,630 | 2.30% | $33.96M | −283,496 | 0.02% |
| Blue Water Life Science Advisors, LP | 1,190,000 | 2.30% | $33.92M | +255,000 | 21.36% |
| Nikko Asset Management Americas, Inc. | 1,188,075 | 2.30% | $33.85M | −287,051 | 0.44% |
| Dimensional Fund Advisors LP | 1,181,077 | 2.28% | $33.66M | −280,837 | 0.01% |
| D. E. Shaw & Co., Inc. | 1,137,660 | 2.20% | $32.42M | +262,752 | 0.02% |
| Jacobs Levy Equity Management, Inc | 995,669 | 1.92% | $28.38M | +131,201 | 0.10% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 227 | 53M | 100.0% | 54 / 77 | 68 / 13 | 7M | 6M |
| Q1 2026 | 191 | 53M | 100.0% | 26 / 74 | 59 / 31 | 9M | 5M |
| Q4 2025 | 200 | 52M | 100.0% | 41 / 63 | 64 / 27 | 6M | 7M |
| Q3 2025 | 187 | 54M | 100.0% | 35 / 63 | 63 / 45 | 12M | 13M |
| Q2 2025 | 197 | 54M | 100.0% | 25 / 67 | 69 / 45 | 5M | 7M |
| Q1 2025 | 218 | 56M | 100.0% | 40 / 64 | 81 / 28 | 9M | 6M |
| Q4 2024 | 210 | 53M | 100.0% | 42 / 89 | 50 / 43 | 9M | 7M |
| Q3 2024 | 215 | 52M | 99.9% | 72 / 64 | 58 / 9 | 15M | 12M |
| Q2 2024 | 154 | 54M | 100.0% | 33 / 50 | 58 / 25 | 6M | 10M |
| Q1 2024 | 146 | 57M | 100.0% | 17 / 47 | 60 / 18 | 7M | 5M |
| Q4 2023 | 147 | 55M | 100.0% | 26 / 47 | 54 / 28 | 8M | 8M |
| Q3 2023 | 150 | 56M | 100.0% | 17 / 51 | 62 / 21 | 4M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CDNA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,554,868 | 3.01% | $44.31M | 0.00% | Jun 30, 2026 |
| ARK Genomic Revolution ETF | 1,531,579 | 2.96% | $66.95M | 4.30% | Jul 31, 2026 |
| Baron Discovery Fund | 1,373,550 | 2.66% | $39.15M | 2.14% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,341,622 | 2.59% | $38.24M | 0.05% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1,143,357 | 2.21% | $32.59M | 0.30% | Jun 30, 2026 |
| Column Small Cap Select Fund | 651,753 | 1.26% | $14.87M | 0.79% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 588,494 | 1.14% | $16.77M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 560,759 | 1.08% | $24.51M | 0.07% | Jul 31, 2026 |
| Strategic Advisers U.S. Total Stock Fund | 493,746 | 0.95% | $11.27M | 0.01% | May 31, 2026 |
| First Eagle Small Cap Opportunity Fund | 485,136 | 0.94% | $21.21M | 0.73% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 473,411 | 0.92% | $13.49M | 0.09% | Jun 30, 2026 |
| iShares Biotechnology ETF | 329,015 | 0.64% | $9.38M | 0.10% | Jun 30, 2026 |
| Invesco Biotechnology & Genome ETF | 325,179 | 0.63% | $14.21M | 5.04% | Jul 31, 2026 |
| JNL Multi-Manager Small Cap Growth Fund | 289,337 | 0.56% | $8.25M | 0.32% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 266,600 | 0.52% | $6.08M | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Walter Hanna JR | President and CEO, Director | 721,448 | 1.39% | Jul 17, 2026 |
| Keith Kennedy | CFO & COO | 211,704 | 0.41% | Sep 15, 2026 |
| Jessica Meng | Chief Commercial Officer | 161,599 | 0.31% | Sep 15, 2026 |
| Jeffrey Adam Novack | Secretary and General Counsel | 106,075 | 0.21% | Aug 6, 2026 |
| Nathan Smith | Chief Financial Officer | 75,000 | 0.14% | Feb 4, 2026 |
| Abhishek Jain | Chief Financial Officer | 319,725 | 0.62% | Aug 5, 2025 |
| Christine Cournoyer | Director | 42,943 | 0.08% | Aug 6, 2026 |
| Michael Goldberg | Director | 152,783 | 0.30% | Aug 6, 2026 |
| George Bickerstaff | Director | 134,061 | 0.26% | Aug 6, 2026 |
| Hannah Valantine | Director | 36,786 | 0.07% | Jul 17, 2026 |
| Fred E. Cohen | Director | 165,060 | 0.32% | Jun 16, 2026 |
| Richard Bryan Riggsbee | Director | 39,312 | 0.08% | Jun 16, 2026 |
| Suresh Gunasekaran | Director | 37,248 | 0.07% | Jun 16, 2026 |
| Arthur A. Torres | Director | 38,665 | 0.07% | May 18, 2026 |
| Peter Maag | Director | 309,846 | 0.60% | Jul 10, 2025 |
| William A. Hagstrom | Director | 73,370 | 0.14% | Jun 13, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jessica Meng Chief Commercial Officer | Sep 12, 2026 | Tax withholding | −6,688 | $52.37 | $350.25K | 161,599 |
| Keith Kennedy CFO & COO | Sep 12, 2026 | Tax withholding | −8,220 | $52.37 | $430.48K | 211,704 |
| Jeffrey Adam Novack Secretary and General Counsel | Aug 5, 2026 | Sale(10b5-1 plan) | −500 | $46.75 | $23.38K | 106,075 |
| Jeffrey Adam Novack Secretary and General Counsel | Aug 5, 2026 | Sale(10b5-1 plan) | −2,188 | $46.15 | $100.98K | 106,575 |
| George Bickerstaff Director | Aug 5, 2026 | Sale | −20,000 | $46.29 | $925.80K | 134,061 |
| Christine Cournoyer Director | Aug 4, 2026 | Sale(10b5-1 plan) | −16,000 | $46.94 | $751.04K | 42,943 |
| Michael Goldberg Director | Aug 4, 2026 | Sale | −44,700 | $47.06 | $2.10M | 61,738 |
| Jeffrey Adam Novack Secretary and General Counsel | Aug 1, 2026 | Tax withholding | −2,872 | $47.85 | $137.43K | 108,763 |
| John Walter Hanna JR President and CEO, Director | Jul 16, 2026 | Sale(10b5-1 plan) | −50,000 | $36.11 | $1.81M | 721,448 |
| John Walter Hanna JR President and CEO, Director | Jul 16, 2026 | Option exercise | +118,000 | $8.20 | $967.60K | 771,448 |
| John Walter Hanna JR President and CEO, Director | Jul 16, 2026 | Sale(10b5-1 plan) | −68,000 | $39.01 | $2.65M | 653,448 |
| Hannah Valantine Director | Jul 16, 2026 | Sale(10b5-1 plan) | −28,679 | $36.14 | $1.04M | 36,786 |
| Hannah Valantine Director | Jul 16, 2026 | Option exercise | +16,048 | $14.19 | $227.72K | 60,340 |
| Hannah Valantine Director | Jul 16, 2026 | Option exercise | +5,125 | $7.96 | $40.80K | 65,465 |
| Hannah Valantine Director | Jul 16, 2026 | Sale(10b5-1 plan) | −100 | $36.55 | $3.65K | 36,686 |
| Hannah Valantine Director | Jul 16, 2026 | Option exercise | +7,606 | $20.56 | $156.38K | 44,292 |
| Michael Goldberg Director | Jul 2, 2026 | Award | +1,746 | – | – | 106,438 |
| John Walter Hanna JR President and CEO, Director | Jul 1, 2026 | Tax withholding | −8,511 | $29.25 | $248.95K | 653,448 |
| Keith Kennedy CFO & COO | Jul 1, 2026 | Tax withholding | −2,930 | $29.25 | $85.70K | 219,924 |
| Jeffrey Adam Novack Secretary and General Counsel | Jul 1, 2026 | Tax withholding | −997 | $29.25 | $29.16K | 111,635 |
| Jessica Meng Chief Commercial Officer | Jul 1, 2026 | Tax withholding | −2,411 | $29.25 | $70.52K | 168,287 |
| John Walter Hanna JR President and CEO, Director | Jun 29, 2026 | Sale(10b5-1 plan) | −39,900 | $29.24 | $1.17M | 661,959 |
| John Walter Hanna JR President and CEO, Director | Jun 29, 2026 | Option exercise | +39,900 | $8.20 | $327.18K | 701,859 |
| John Walter Hanna JR President and CEO, Director | Jun 26, 2026 | Sale(10b5-1 plan) | −100 | $29.00 | $2.90K | 661,959 |
| John Walter Hanna JR President and CEO, Director | Jun 26, 2026 | Option exercise | +100 | $8.20 | $820 | 662,059 |
| John Walter Hanna JR President and CEO, Director | Jun 15, 2026 | Option exercise | +15,676 | $8.20 | $128.54K | 661,959 |
| John Walter Hanna JR President and CEO, Director | Jun 15, 2026 | Sale(10b5-1 plan) | −17,683 | $24.03 | $424.92K | 631,959 |
| Hannah Valantine Director | Jun 15, 2026 | Sale(10b5-1 plan) | −12,103 | $23.11 | $279.70K | 36,686 |
| Christine Cournoyer Director | Jun 12, 2026 | Award | +9,795 | – | – | 58,943 |
| Michael Goldberg Director | Jun 12, 2026 | Award | +9,795 | – | – | 195,737 |
| George Bickerstaff Director | Jun 12, 2026 | Award | +9,795 | – | – | 154,061 |
| Richard Bryan Riggsbee Director | Jun 12, 2026 | Award | +9,795 | – | – | 39,312 |
| Fred E. Cohen Director | Jun 12, 2026 | Award | +9,795 | – | – | 165,060 |
| Suresh Gunasekaran Director | Jun 12, 2026 | Award | +9,795 | – | – | 37,248 |
| Hannah Valantine Director | Jun 12, 2026 | Award | +9,795 | – | – | 48,789 |
| John Walter Hanna JR President and CEO, Director | Jun 11, 2026 | Option exercise | +13,618 | $8.20 | $111.67K | 646,283 |
| John Walter Hanna JR President and CEO, Director | Jun 11, 2026 | Sale(10b5-1 plan) | −21,998 | $24.02 | $528.39K | 649,642 |
| Jeffrey Adam Novack Secretary and General Counsel | Jun 6, 2026 | Tax withholding | −1,292 | $21.95 | $28.36K | 112,632 |
| John Walter Hanna JR President and CEO, Director | Jun 4, 2026 | Option exercise | +706 | $8.20 | $5.79K | 632,665 |
| John Walter Hanna JR President and CEO, Director | Jun 4, 2026 | Sale(10b5-1 plan) | −4,835 | $24.00 | $116.04K | 671,640 |
| Arthur A. Torres Director | May 15, 2026 | Sale | −6,484 | $19.89 | $128.97K | 38,665 |
| Arthur A. Torres Director | May 14, 2026 | Sale | −4,086 | $20.97 | $85.68K | 45,149 |
| Jeffrey Adam Novack Secretary and General Counsel | May 5, 2026 | Sale(10b5-1 plan) | −2,688 | $20.68 | $55.59K | 113,924 |
| Jeffrey Adam Novack Secretary and General Counsel | May 1, 2026 | Tax withholding | −2,873 | $21.50 | $61.77K | 116,612 |
| Keith Kennedy CFO & COO | Apr 20, 2026 | Award | +24,134 | – | – | 221,548 |
| John Walter Hanna JR President and CEO, Director | Apr 16, 2026 | Sale(10b5-1 plan) | −10,282 | $21.12 | $217.16K | 676,475 |
| John Walter Hanna JR President and CEO, Director | Apr 15, 2026 | Tax withholding | −62,049 | $17.57 | $1.09M | 686,757 |
| Jeffrey Adam Novack Secretary and General Counsel | Apr 6, 2026 | Tax withholding | −1,892 | $17.82 | $33.72K | 119,485 |
| Michael Goldberg Director | Apr 2, 2026 | Award | +1,981 | – | – | 185,942 |
| Jessica Meng Chief Commercial Officer | Apr 1, 2026 | Tax withholding | −7,386 | $17.87 | $131.99K | 169,392 |
| Jeffrey Adam Novack Secretary and General Counsel | Apr 1, 2026 | Tax withholding | −3,987 | $17.87 | $71.25K | 121,377 |
| John Walter Hanna JR President and CEO, Director | Apr 1, 2026 | Tax withholding | −35,037 | $17.87 | $626.11K | 748,806 |
| Keith Kennedy CFO & COO | Apr 1, 2026 | Tax withholding | −11,725 | $17.87 | $209.53K | 197,414 |
| Michael Goldberg Director | Mar 31, 2026 | Option exercise | +5,255 | $5.02 | $26.38K | 162,716 |
| Michael Goldberg Director | Mar 31, 2026 | Option exercise | +11,500 | $1.22 | $14.03K | 183,961 |
| Michael Goldberg Director | Mar 31, 2026 | Option exercise | +9,745 | $4.95 | $48.24K | 172,461 |
| Jeffrey Adam Novack Secretary and General Counsel | Feb 3, 2026 | Sale(10b5-1 plan) | −4,441 | $20.56 | $91.31K | 125,364 |
| Jeffrey Adam Novack Secretary and General Counsel | Feb 2, 2026 | Tax withholding | −2,970 | $20.42 | $60.65K | 129,805 |
| Jeffrey Adam Novack Secretary and General Counsel | Feb 2, 2026 | Tax withholding | −2,492 | $20.42 | $50.89K | 132,775 |
| Jeffrey Adam Novack Secretary and General Counsel | Feb 2, 2026 | Award | +4,342 | – | – | 135,267 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Maag Peter Director | Aug 17, 2026 | 9,122 | $423.09K | Aug 17, 2026 | Restricted Stock |
| Maag Peter Director | Aug 14, 2026 | 7,000 | $317.11K | Aug 14, 2026 | Restricted Stock |
| Maag Peter Director | Aug 13, 2026 | 7,000 | $329.51K | Aug 13, 2026 | Restricted Stock |
| Maag Peter Director | Aug 12, 2026 | 7,000 | $328.24K | Aug 12, 2026 | Restricted Stock |
| Maag Peter Director | Aug 11, 2026 | 7,000 | $333.85K | Aug 11, 2026 | Restricted Stock |
| Torres Arthur Director | Aug 10, 2026 | 4,200 | $200.48K | Aug 10, 2026 | Restricted Stock |
| Maag Peter Director | Aug 10, 2026 | 6,902 | $328.95K | Aug 10, 2026 | Restricted Stock |
| Maag Peter Director | Aug 7, 2026 | 27,332 | $1.25M | Aug 7, 2026 | Stock Option Exercise |
| Maag Peter Director | Aug 5, 2026 | 46,963 | $2.18M | Aug 5, 2026 | Restricted Stock |
| Novack Jeffrey Officer | Aug 5, 2026 | 2,688 | $126.58K | Aug 5, 2026 | Restricted Stock Units |
| W. Bickerstaff George Director | Aug 5, 2026 | 20,000 | $925.70K | Aug 5, 2026 | Compensation for Past Services |
| M. Cournoyer Christine Director | Aug 4, 2026 | 16,000 | $753.44K | Aug 4, 2026 | Acquired as compensation -- Restricted Stock Units |
| Cournoyer Christine Director | Aug 4, 2026 | 31,943 | $1.52M | Aug 4, 2026 | Stock Option Exercise |
| Maag Peter Director | Aug 4, 2026 | 75,653 | $3.58M | Aug 4, 2026 | Stock Option Exercise |
| D. Goldberg Fam Trust Michael Director | Aug 4, 2026 | 44,700 | $2.10M | Aug 4, 2026 | Restricted Stock Vesting Under a Registered Plan |